Legacy Capital Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Sell |
947
-262
| -22% | -$106K | 0.09% | 257 |
|
|
2025
Q1 | $602K | Sell |
1,209
-433
| -26% | -$216K | 0.15% | 148 |
|
|
2024
Q4 | $854K | Sell |
1,642
-70
| -4% | -$36.4K | 0.21% | 96 |
|
|
2024
Q3 | $1.06M | Sell |
1,712
-71
| -4% | -$43.9K | 0.21% | 101 |
|
|
2024
Q2 | $986K | Buy |
+1,783
| New | +$986K | 0.25% | 80 |
|
|
2024
Q1 | – | Sell |
-1,885
| Closed | -$1M | – | 322 |
|
|
2023
Q4 | $1M | Buy |
1,885
+218
| +13% | +$116K | 0.28% | 80 |
|
|
2023
Q3 | $844K | Buy |
+1,667
| New | +$844K | 0.23% | 89 |
|
|
2023
Q2 | – | Sell |
-1,560
| Closed | -$899K | – | 218 |
|
|
2023
Q1 | $899K | Buy |
+1,560
| New | +$899K | 0.25% | 87 |
|
|
2021
Q1 | – | Sell |
-399
| Closed | -$186K | – | 103 |
|
|
2020
Q4 | $186K | Buy |
+399
| New | +$186K | 0.08% | 77 |
|